Your Messages Inbox
Your Article Summary
See Latest Articles(Click the title below to leave the MDLinx Network and go to the Journal's Website)
Change to Directors details
Shire, 02/06/09
Shire plc, the global specialty biopharmaceutical company, announces that Mr Matthew Emmens, non-executive Chairman of Shire, has been appointed President of Vertex Pharmaceuticals Incorporated with immediate effect and that Mr Emmens will in addition become Chairman and Chief Executive Officer of Vertex in May 2009 when the current Chief Executive Officer retires.
Today in Execs on the Move...keeping you current
Receive free subspecialty "5-minute updates" via email
Bristol-Myers Squibb Announces Appointment of Charles Bancroft as Acting Chief Financial Officer
Bristol Myers-Squibb Company, 12/15/09
AHIMA Selects its Leader
HealthDataManagement, 12/14/09
Robert J. Bertolini Elected to Genzyme's Board of Directors
Genzyme, 12/09/09
Article Search
Sponsor